We are live on ! Find out more
IHAM

Integral Health Asset Management Portfolio holdings

AUM $2.09B
1-Year Est. Return 112.84%
This Fund
S&P 500
This Quarter Est. Return
+8.83%
1 Year Est. Return
+112.84%
3 Year Est. Return
+485.32%
5 Year Est. Return
+783.01%
10 Year Est. Return
–
AUM
$1.17B
AUM Growth
+$284M
Cap. Flow
+$340M
Cap. Flow %
29%
Top 10 Hldgs %
38.67%
Holding
102
New
36
Increased
28
Reduced
14
Closed
19

Top Buys

Rank Stock Value
1
CNC icon
Centene
CNC
+$31.2M
2
CAH icon
Cardinal Health
CAH
+$29.2M
3
VERA icon
Vera Therapeutics
VERA
+$28.8M
4
CVS icon
CVS Health
CVS
+$28.1M
5
LLY icon
Eli Lilly
LLY
+$23.2M

Top Sells

Rank Stock Value
1
LBPH
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
+$35M
2
NVS icon
Novartis
NVS
+$23M
3
THC icon
Tenet Healthcare
THC
+$19.3M
4
ACLX
Arcellx
ACLX
+$15.1M
5
MDT icon
Medtronic
MDT
+$13M

Sector Composition

Rank Sector Weight
1 Healthcare 96.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACLX
51
DELISTED
Arcellx
ACLX
$7.67M 0.65%
100,000
-175,000
-64% -$15.1M
TARA icon
52
Protara Therapeutics
TARA
$220M
$7.39M 0.63%
+1,400,000
New +$4.52M
KROS icon
53
Keros Therapeutics
KROS
$211M
$7.12M 0.61%
450,000
+250,000
+125% +$13M
RGNX icon
54
Regenxbio
RGNX
$703M
$6.96M 0.59%
900,000
-375,000
-29% -$3.52M
QDEL icon
55
QuidelOrtho
QDEL
$959M
$6.68M 0.57%
150,000
+25,000
+20% +$1.02M
CPRX
56
DELISTED
Catalyst Pharmaceutical
CPRX
$6.26M 0.53%
300,000
-100,000
-25% -$2.15M
VKTX icon
57
Viking Therapeutics
VKTX
$3.94B
$6.04M 0.51%
+150,000
New +$8.55M
BRKR icon
58
Bruker
BRKR
$8.69B
$5.86M 0.5%
100,000
-35,000
-26% -$2.07M
RGEN icon
59
Repligen
RGEN
$9.3B
$5.76M 0.49%
+40,000
New +$5.74M
ALHC icon
60
Alignment Healthcare
ALHC
$2.74B
$5.63M 0.48%
+500,000
New +$5.85M
ILMN icon
61
Illumina
ILMN
$29.1B
$5.35M 0.46%
+40,000
New +$5.7M
PODD icon
62
Insulet
PODD
$10B
$5.22M 0.45%
+20,000
New +$5.04M
ARWR icon
63
Arrowhead Research
ARWR
$12.6B
$5.17M 0.44%
+275,000
New +$5.66M
NRIX icon
64
Nurix Therapeutics
NRIX
$2.69B
$4.71M 0.4%
250,000
+50,000
+25% +$1.15M
WBA
65
DELISTED
Walgreens Boots Alliance
WBA
$4.67M 0.4%
+500,000
New +$4.64M
TGTX icon
66
TG Therapeutics
TGTX
$7.64B
$4.51M 0.38%
+150,000
New +$4.3M
PLRX icon
67
Pliant Therapeutics
PLRX
$63.8M
$3.95M 0.34%
300,000
– –
SWTX
68
DELISTED
SpringWorks Therapeutics
SWTX
$3.61M 0.31%
+100,000
New +$3.49M
DYN icon
69
Dyne Therapeutics
DYN
$4.99B
$3.53M 0.3%
+150,000
New +$4.44M
MREO
70
Mereo BioPharma
MREO
$48.8M
$3.5M 0.3%
1,000,000
– –
SANA icon
71
Sana Biotechnology
SANA
$1.13B
$3.26M 0.28%
2,000,000
+200,000
+11% +$596K
ZNTL icon
72
Zentalis Pharmaceuticals
ZNTL
$295M
$3.18M 0.27%
+1,050,000
New +$3.44M
TERN
73
DELISTED
Terns Pharmaceuticals
TERN
$2.49M 0.21%
450,000
+150,000
+50% +$1.02M
RZLT icon
74
Rezolute
RZLT
$445M
$2.45M 0.21%
500,000
+250,000
+100% +$1.26M
STAA icon
75
STAAR Surgical
STAA
$1.24B
$2.43M 0.21%
100,000
+50,000
+100% +$1.43M
1 2
3
4 5

Similar funds

CL
CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return
ACM
Analog Century Management New York $2.09B AUM 186.85% 1-Year Est. Return
ACG
Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return
NSUP
NLB Skladi upravljanje premozenja Ljubljana $2.09B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return

Integral Health Asset Management's Q4 2024 Portfolio in Review

As of Q4 2024, Integral Health Asset Management held 102 positions worth $1.17B, up 32% from $889M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Integral Health Asset Management deployed $340M of net new capital in Q4 2024, opening 36 new positions and adding to 28 existing holdings. Its largest new stake was Centene: 500,000 shares worth $30.3M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 96% a quarter earlier.

On the sell side, the largest reduction was Tenet Healthcare, an estimated $19.3M trimmed.

  • Integral Health Asset Management's largest Q4 2024 buy was Centene: 500,000 shares worth $30.3M.
  • Integral Health Asset Management added most to Vera Therapeutics in Q4 2024, an estimated $28.8M increase.
  • Integral Health Asset Management's biggest Q4 2024 reduction was Tenet Healthcare, cutting an estimated $19.3M.
  • Integral Health Asset Management fully exited Longboard Pharmaceuticals, Inc. Common Stock in Q4 2024, selling an estimated $35M.
  • Integral Health Asset Management's ten largest holdings make up 39% of its $1.17B portfolio in Q4 2024.
  • Integral Health Asset Management opened 36 new positions and closed 19 in Q4 2024.
  • Integral Health Asset Management's portfolio value rose 32% quarter-over-quarter to $1.17B.

Based on Integral Health Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.